|
Diabetes, Vol 45, Issue 2 257-261, Copyright © 1996 by American Diabetes Association
Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells
K Moens, H Heimberg, D Flamez, P Huypens, E Quartier, Z Ling, D Pipeleers, S Gremlich, B Thorens and F Schuit
Diabetes Research Center, Vrije Universiteit Brussel, Belgium.
Rat pancreatic alpha- and beta-cells are critically dependent on hormonal
signals generating cyclic AMP (cAMP) as a synergistic messenger for
nutrient-induced hormone release. Several peptides of the glucagon-secretin
family have been proposed as physiological ligands for cAMP production in
beta-cells, but their relative importance for islet function is still
unknown. The present study shows expression at the RNA level in beta-cells
of receptors for glucagon, glucose-dependent insulinotropic polypeptide
(GIP), and glucagon-like peptide I(7-36) amide (GLP-I), while RNA from
islet alpha-cells hybridized only with GIP receptor cDNA. Western blots
confirmed that GLP-I receptors were expressed in beta-cells and not in
alpha-cells. Receptor activity, measured as cellular cAMP production after
exposing islet beta-cells for 15 min to a range of peptide concentrations,
was already detected using 10 pmol/l GLP-I and 50 pmol/l GIP but required 1
nmol/l glucagon. EC50 values of GLP-I- and GIP-induced cAMP formation were
comparable (0.2 nmol/l) and 45-fold lower than the EC50 of glucagon (9
nmol/l). Maximal stimulation of cAMP production was comparable for the
three peptides. In purified alpha-cells, 1 nmol/l GLP-I failed to increase
cAMP levels, while 10 pmol/l to 10 nmol/l GIP exerted similar stimulatory
effects as in beta-cells. In conclusion, these data show that stimulation
of glucagon, GLP-I, and GIP receptors in rat beta-cells causes cAMP
production required for insulin release, while adenylate cyclase in
alpha-cells is positively regulated by GIP.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Holst
The Physiology of Glucagon-like Peptide 1
Physiol Rev,
October 1, 2007;
87(4):
1409 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Xu, H. Kaneto, D. R. Laybutt, V. F. Duvivier-Kali, N. Trivedi, K. Suzuma, G. L. King, G. C. Weir, and S. Bonner-Weir
Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia: Possible Contribution to Impaired Incretin Effects in Diabetes
Diabetes,
June 1, 2007;
56(6):
1551 - 1558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev.,
February 1, 2007;
28(1):
84 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Deacon, A. Plamboeck, M. M. Rosenkilde, J. de Heer, and J. J. Holst
GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations
Am J Physiol Endocrinol Metab,
September 1, 2006;
291(3):
E468 - E475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N Friedrichsen, N. Neubauer, Y. C Lee, V. K Gram, N. Blume, J. S Petersen, J. H Nielsen, and A. Moldrup
Stimulation of pancreatic {beta}-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
J. Endocrinol.,
March 1, 2006;
188(3):
481 - 492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Franklin, J. Gromada, A. Gjinovci, S. Theander, and C. B. Wollheim
{beta}-Cell Secretory Products Activate {alpha}-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release
Diabetes,
June 1, 2005;
54(6):
1808 - 1815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Masur, E. C. Tibaduiza, C. Chen, B. Ligon, and M. Beinborn
Basal Receptor Activation by Locally Produced Glucagon-Like Peptide-1 Contributes to Maintaining {beta}-Cell Function
Mol. Endocrinol.,
May 1, 2005;
19(5):
1373 - 1382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Valerio, A. Franzese, M. Salerno, G. Muzzi, G. Cecere, K. I. Temple, and J. P. Shield
{beta}-Cell Dysfunction in Classic Transient Neonatal Diabetes Is Characterized by Impaired Insulin Response to Glucose but Normal Response to Glucagon
Diabetes Care,
October 1, 2004;
27(10):
2405 - 2408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hinke, K. Hellemans, and F. C. Schuit
Plasticity of the {beta} cell insulin secretory competence: preparing the pancreatic {beta} cell for the next meal
J. Physiol.,
July 15, 2004;
558(2):
369 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hansotia, L. L. Baggio, D. Delmeire, S. A. Hinke, Y. Yamada, K. Tsukiyama, Y. Seino, J. J. Holst, F. Schuit, and D.J. Drucker
Double Incretin Receptor Knockout (DIRKO) Mice Reveal an Essential Role for the Enteroinsular Axis in Transducing the Glucoregulatory Actions of DPP-IV Inhibitors
Diabetes,
May 1, 2004;
53(5):
1326 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pamir, F. C. Lynn, A. M. J. Buchan, J. Ehses, S. A. Hinke, J. A. Pospisilik, K. Miyawaki, Y. Yamada, Y. Seino, C. H. S. McIntosh, et al.
Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis
Am J Physiol Endocrinol Metab,
May 1, 2003;
284(5):
E931 - E939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Vahl, B. W. Paty, B. D. Fuller, R. L. Prigeon, and D. A. D'Alessio
Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on Intravenous Glucose Tolerance and Glucose-Induced Insulin Secretion in Healthy Humans
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1772 - 1779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev.,
March 1, 2003;
55(1):
167 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Harndahl, X.-J. Jing, R. Ivarsson, E. Degerman, B. Ahren, V. C. Manganiello, E. Renstrom, and L. S. Holst
Important Role of Phosphodiesterase 3B for the Stimulatory Action of cAMP on Pancreatic beta -Cell Exocytosis and Release of Insulin
J. Biol. Chem.,
September 27, 2002;
277(40):
37446 - 37455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Tompkins, K. D. Nullmeyer, S. M. Murphy, C. S. Weber, and R. M. Lynch
Regulation of secretory granule pH in insulin-secreting cells
Am J Physiol Cell Physiol,
August 1, 2002;
283(2):
C429 - C437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Moens, V. Berger, J.-M. Ahn, C. Van Schravendijk, V. J. Hruby, D. Pipeleers, and F. Schuit
Assessment of the Role of Interstitial Glucagon in the Acute Glucose Secretory Responsiveness of In Situ Pancreatic {beta}-Cells
Diabetes,
March 1, 2002;
51(3):
669 - 675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Lawrence, H. S. Bhatt, and R. A. Easom
NFAT Regulates Insulin Gene Promoter Activity in Response to Synergistic Pathways Induced by Glucose and Glucagon-Like Peptide-1
Diabetes,
March 1, 2002;
51(3):
691 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kashima, T. Miki, T. Shibasaki, N. Ozaki, M. Miyazaki, H. Yano, and S. Seino
Critical Role of cAMP-GEFII{middle dot}Rim2 Complex in Incretin-potentiated Insulin Secretion
J. Biol. Chem.,
November 30, 2001;
276(49):
46046 - 46053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. C. Lynn, N. Pamir, E. H.C. Ng, C. H.S. McIntosh, T. J. Kieffer, and R. A. Pederson
Defective Glucose-Dependent Insulinotropic Polypeptide Receptor Expression in Diabetic Fatty Zucker Rats
Diabetes,
May 1, 2001;
50(5):
1004 - 1011.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Lacroix, N. N'Diaye, J. Tremblay, and P. Hamet
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's Syndrome
Endocr. Rev.,
February 1, 2001;
22(1):
75 - 110.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. C. Schuit, P. Huypens, H. Heimberg, and D. G. Pipeleers
Glucose Sensing in Pancreatic {beta}-Cells: A Model for the Study of Other Glucose-Regulated Cells in Gut, Pancreas, and Hypothalamus
Diabetes,
January 1, 2001;
50(1):
1 - 11.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. M. Sherwood, S. L. Krueckl, and J. E. McRory
The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon Superfamily
Endocr. Rev.,
December 1, 2000;
21(6):
619 - 670.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. T. Lewis, B. Dayanandan, J. F. Habener, and T. J. Kieffer
Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist
Endocrinology,
October 1, 2000;
141(10):
3710 - 3716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Kieffer and J. Francis Habener
The Glucagon-Like Peptides
Endocr. Rev.,
December 1, 1999;
20(6):
876 - 913.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. B. Wheeler, R. W. Gelling, S. A. Hinke, B. Tu, R. A. Pederson, F. Lynn, J. Ehses, and C. H. S. McIntosh
Characterization of the Carboxyl-terminal Domain of the Rat Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor. A ROLE FOR SERINES 426 AND 427 IN REGULATING THE RATE OF INTERNALIZATION
J. Biol. Chem.,
August 27, 1999;
274(35):
24593 - 24601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. F. Salapatek, P. E. MacDonald, H. Y. Gaisano, and M. B. Wheeler
Mutations to the Third Cytoplasmic Domain of the Glucagon-Like Peptide 1 (GLP-1) Receptor Can Functionally Uncouple GLP-1-Stimulated Insulin Secretion in HIT-T15 Cells
Mol. Endocrinol.,
August 1, 1999;
13(8):
1305 - 1317.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Portois, B. Maget, M. Tastenoy, J. Perret, and M. Svoboda
Identification of a Glucose Response Element in the Promoter of the Rat Glucagon Receptor Gene
J. Biol. Chem.,
March 19, 1999;
274(12):
8181 - 8190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Aspinwall, J. R. T. Lakey, and R. T. Kennedy
Insulin-stimulated Insulin Secretion in Single Pancreatic Beta Cells
J. Biol. Chem.,
March 5, 1999;
274(10):
6360 - 6365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Serre, W. Dolci, E. Schaerer, L. Scrocchi, D. Drucker, S. Efrat, and B. Thorens
Exendin-(9-39) Is an Inverse Agonist of the Murine Glucagon-Like Peptide-1 Receptor: Implications for Basal Intracellular Cyclic Adenosine 3',5'-Monophosphate Levels and {beta}-Cell Glucose Competence
Endocrinology,
November 1, 1998;
139(11):
4448 - 4454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Mathi, Y. Chan, X. Li, and M. B. Wheeler
Scanning of the Glucagon-Like Peptide-1 Receptor Localizes G Protein-Activating Determinants Primarily to the N Terminus of the Third Intracellular Loop
Mol. Endocrinol.,
April 1, 1997;
11(4):
424 - 432.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. A. Aspinwall, W.-J. Qian, M. G. Roper, R. N. Kulkarni, C. R. Kahn, and R. T. Kennedy
Roles of Insulin Receptor Substrate-1, Phosphatidylinositol 3-Kinase, and Release of Intracellular Ca2+ Stores in Insulin-stimulated Insulin Secretion in beta -Cells
J. Biol. Chem.,
July 14, 2000;
275(29):
22331 - 22338.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Diabetes Association.
|
|
| |
|